ArticleCureus2025
Brown Tumor: An Uncommon Manifestation of Severe Hyperparathyroidism.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Severe Tertiary Hyperparathyroidism with Brown Tumor and Multisystem Complications Mimicking Plasma Cell Dyscrasia in a Middle-Aged Man with Childhood-Onset FSGS.Journal of investigative medicine high impact case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brown tumor is now an uncommon form of osteitis fibrosa cystica. It results from an imbalance in bone remodeling, which leads to osteolytic lesions. This process, marked by microfractures and discoloration, is triggered by persistently elevated parathyroid hormone levels in end-stage renal disease (ESRD) patients with tertiary hyperparathyroidism. Our case highlights a large brown tumor in the maxilla causing significant facial deformity. A 34-year-old female patient with ESRD had multiple admissions to our facility for various reasons. She was non-adherent to her dialysis treatment regimen and medications. She had a facial mass that had doubled in size over a year. Laboratory results showed elevated calcium and phosphorus levels and extremely elevated parathyroid hormone (PTH) levels. A computed tomography (CT) scan showed an exophytic mass arising from the anterior left maxilla, suggestive of a brown tumor. A sestamibi parathyroid scan and neck sonogram did not confirm hyperplastic parathyroid glands. Nevertheless, a biopsy of the mass showed multinucleated giant cells and stromal spindle cells consistent with a brown tumor. The patient would have benefited from a parathyroidectomy, but she refused and signed out against medical advice. Brown tumors are now uncommon in the USA due to effective medical management of bone mineral disorders associated with ESRD and efficient renal replacement therapy. However, our case emphasizes that brown tumors may occur in ESRD patients who do not adhere to their treatment regimen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.